Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

IL-17 and certain immune cells are linked to more severe alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Fetal skin has unique immune cells different from adult skin.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Innate lymphoid cells type 1 may contribute to alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Crataegi Fructus water extract helps hair grow better and thicker.

Yikgeebohyul-tang promotes hair growth and could help treat hair loss.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

ILC1 cells contribute to hair loss in alopecia areata.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Hair gels may cause split ends in children.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Effective treatments for severe alopecia areata are still lacking.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.